Impact of cytomegalovirus infection in lung transplant patients under universal prophylaxis: single-center experience in Brazil.
Bugano
D D G
DD
Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Campos
S V
SV
Afonso
J E
JE
Caramori
M L
ML
Teixeira
R H O B
RH
Carraro
R M
RM
Strabelli
T M V
TM
Machado
C M
CM
Samano
M N
MN
Pêgo-Fernandes
P
P
Jatene
F B
FB
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D000077552:Basiliximab; D001938:Brazil; D001987:Bronchiectasis / Q000188:drug therapy; D015331:Cohort Studies; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000601:surgery; D003586:Cytomegalovirus Infections / Q000453:epidemiology* / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D018579:Patient Selection; D011183:Postoperative Complications / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000601:surgery; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone